Office-Based Procedures in the Management of Hemorrhoidal Disease: Rubber Band Ligation Versus Sclerotherapy - Systematic Review and Meta-Analysis

Overview

Journal GE Port J Gastroenterol

Specialty Gastroenterology

Date 2022 Dec 22

PMID 36545183

Authors

Paulo Salgueiro

Maria Ines Ramos

Fernando Castro-Pocas

Diogo Libanio

Affiliations

Soon will be listed here.

Abstract

Introduction: The most frequently used office-based procedures in hemorrhoidal disease (HD) are rubber band ligation (RBL) and sclerotherapy. Few studies have been published comparing the various types of instrumental therapy. The aim of this systematic review and meta-analysis was to compare the efficacy and safety of sclerotherapy and RBL.

Methods: Three online databases were searched. Efficacy (control of symptoms, prolapse, bleeding and pain, patients' satisfaction, and disease recurrence) and safety (complications, such as pain and bleeding) were the assessed outcomes. Pooled relative risks (RR) were computed for each outcome using a random-effects model, and heterogeneity was assessed by Cochran's Q test and .

Results: Six RCTs and three cohort studies were included. Control of prolapse and bleeding was significantly higher with RBL (93.1% RBL vs. 66.4% sclerotherapy, RR 1.34, 95% CI 1.12-1.60 and 89.1% RBL vs. 78.7% SCL, RR 1.17, 95% CI 1.02-1.34, respectively). Both techniques had similar results in terms of pain relief, overall control of symptoms, and risk of recurrence at 3 months. Although patient satisfaction was significantly higher with RBL (77.8% RBL vs. 46.7% sclerotherapy, RR 1.59, 95% CI 1.01-2.50), post-procedural pain was significantly higher with this technique (24% RBL vs. 14% sclerotherapy, RR 1.74, 95% CI 1.32-2.28). There was no significant difference regarding post-procedure bleeding (11.1% RBL vs. 8.7% sclerotherapy, RR 1.29, 95% CI 0.86-1.94). In the subgroup analysis, according to the HD grade, post-procedure pain was higher with RBL only in HD grade II (vs. HD grade I-III).

Conclusions: RBL performs better than sclerotherapy in controlling HD symptoms, specifically prolapse and bleeding, although post-procedural pain is a frequent complication. Recurrence is similar with both procedures. While waiting for the publication of results with sclerotherapy with new sclerosants, RBL remains the office-based treatment of choice in HD.

Citing Articles

Shifting Paradigms in Hemorrhoid Management: The Emergence and Impact of Cap-Assisted Endoscopic Sclerotherapy.

Wang X, Wu X, Wen Q, Cui B, Zhang F J Clin Med. 2024; 13(23).

PMID: 39685741 PMC: 11641974. DOI: 10.3390/jcm13237284.

Endoscopic polidocanol foam sclerobanding for treatment of internal hemorrhoids: A novel outpatient procedure.

Mou A, Wang Y World J Gastroenterol. 2024; 30(42):4583-4586.

PMID: 39563748 PMC: 11572621. DOI: 10.3748/wjg.v30.i42.4583.

The Italian Unitary Society of Colon-Proctology (Società Italiana Unitaria di Colonproctologia) guidelines for the management of acute and chronic hemorrhoidal disease.

Brillantino A, Renzi A, Talento P, Brusciano L, Marano L, Grillo M Ann Coloproctol. 2024; 40(4):287-320.

PMID: 39228195 PMC: 11375232. DOI: 10.3393/ac.2023.00871.0124.

Precision and Power: A Comprehensive Review of Exploring the Role of Laser Treatment in Hemorrhoidal Management.

Surya D, Gharde P Cureus. 2024; 16(5):e60011.

PMID: 38854246 PMC: 11162813. DOI: 10.7759/cureus.60011.

Injection sclerotherapy for the treatment of haemorrhoids in anticoagulated patients.

Batra P, OConnor A, Walmsley J, Baraza W, Sharma A Ann R Coll Surg Engl. 2024; 107(1):25-28.

PMID: 38174849 PMC: 11658878. DOI: 10.1308/rcsann.2023.0097.

References

Fernandes V, Fonseca J . Polidocanol Foam Injected at High Doses with Intravenous Needle: The (Almost) Perfect Treatment of Symptomatic Internal Hemorrhoids. GE Port J Gastroenterol. 2019; 26(3):169-175. PMC: 6528101. DOI: 10.1159/000492202. View

MacRae H, McLeod R . Comparison of hemorrhoidal treatment modalities. A meta-analysis. Dis Colon Rectum. 1995; 38(7):687-94. DOI: 10.1007/BF02048023. View

Cocorullo G, Tutino R, Falco N, Licari L, Orlando G, Fontana T . The non-surgical management for hemorrhoidal disease. A systematic review. G Chir. 2017; 38(1):5-14. PMC: 5730401. DOI: 10.11138/gchir/2017.38.1.005. View

Sandler R, Peery A . Rethinking What We Know About Hemorrhoids. Clin Gastroenterol Hepatol. 2018; 17(1):8-15. PMC: 7075634. DOI: 10.1016/j.cgh.2018.03.020. View

Iyer V, Shrier I, Gordon P . Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum. 2004; 47(8):1364-70. DOI: 10.1007/s10350-004-0591-2. View

Lohsiriwat V . Approach to hemorrhoids. Curr Gastroenterol Rep. 2013; 15(7):332. DOI: 10.1007/s11894-013-0332-6. View

Sun Z, Migaly J . Review of Hemorrhoid Disease: Presentation and Management. Clin Colon Rectal Surg. 2016; 29(1):22-9. PMC: 4755769. DOI: 10.1055/s-0035-1568144. View

Davis B, Lee-Kong S, Migaly J, Feingold D, Steele S . The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids. Dis Colon Rectum. 2018; 61(3):284-292. DOI: 10.1097/DCR.0000000000001030. View

Albuquerque A . Rubber band ligation of hemorrhoids: A guide for complications. World J Gastrointest Surg. 2016; 8(9):614-620. PMC: 5037334. DOI: 10.4240/wjgs.v8.i9.614. View

10.

Lohsiriwat V . Hemorrhoids: from basic pathophysiology to clinical management. World J Gastroenterol. 2012; 18(17):2009-17. PMC: 3342598. DOI: 10.3748/wjg.v18.i17.2009. View

11.

Lohsiriwat V . Treatment of hemorrhoids: A coloproctologist's view. World J Gastroenterol. 2015; 21(31):9245-52. PMC: 4541377. DOI: 10.3748/wjg.v21.i31.9245. View

12.

Acheson A, Scholefield J . Management of haemorrhoids. BMJ. 2008; 336(7640):380-3. PMC: 2244760. DOI: 10.1136/bmj.39465.674745.80. View

13.

Cengiz T, Gorgun E . Hemorrhoids: A range of treatments. Cleve Clin J Med. 2019; 86(9):612-620. DOI: 10.3949/ccjm.86a.18079. View

14.

Abiodun A, Alatise O, Okereke C, Adesunkanmi A, Eletta E, Gomna A . Comparative study of endoscopic band ligation versus injection sclerotherapy with 50% dextrose in water, in symptomatic internal haemorrhoids. Niger Postgrad Med J. 2020; 27(1):13-20. DOI: 10.4103/npmj.npmj_128_19. View

15.

Sneider E, Maykel J . Diagnosis and management of symptomatic hemorrhoids. Surg Clin North Am. 2010; 90(1):17-32, Table of Contents. DOI: 10.1016/j.suc.2009.10.005. View

16.

Awad A, Soliman H, Saif S, Darwish A, Mosaad S, Elfert A . A prospective randomised comparative study of endoscopic band ligation versus injection sclerotherapy of bleeding internal haemorrhoids in patients with liver cirrhosis. Arab J Gastroenterol. 2012; 13(2):77-81. DOI: 10.1016/j.ajg.2012.03.008. View

17.

Nastasa V, Samaras K, Ampatzidis C, Karapantsios T, Trelles M, Moreno-Moraga J . Properties of polidocanol foam in view of its use in sclerotherapy. Int J Pharm. 2014; 478(2):588-96. DOI: 10.1016/j.ijpharm.2014.11.056. View

18.

Siddiqui U, Barth B, Banerjee S, Bhat Y, Chauhan S, Gottlieb K . Devices for the endoscopic treatment of hemorrhoids. Gastrointest Endosc. 2013; 79(1):8-14. DOI: 10.1016/j.gie.2013.07.021. View

19.

Jamjoom A, Jamal Y . A comparative study of different treatments of hemorrhoids. Ann Saudi Med. 1991; 11(1):73-9. DOI: 10.5144/0256-4947.1991.73. View

20.

Kanellos I, Goulimaris I, Christoforidis E, Kelpis T, Betsis D . A comparison of the simultaneous application of sclerotherapy and rubber band ligation, with sclerotherapy and rubber band ligation applied separately, for the treatment of haemorrhoids: a prospective randomized trial. Colorectal Dis. 2003; 5(2):133-8. DOI: 10.1046/j.1463-1318.2003.00395.x. View